JP Morgan Chase’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.72M Buy
209,823
+26,142
+14% +$1.05M ﹤0.01% 2810
2025
Q4
$6.88M Sell
183,681
-115,069
-39% -$3.86M ﹤0.01% 3031
2025
Q3
$8.83M Buy
298,750
+42,603
+17% +$990K ﹤0.01% 2830
2025
Q2
$6.04M Sell
256,147
-240,038
-48% -$5.01M ﹤0.01% 2982
2025
Q1
$8.98M Buy
496,185
+451,820
+1,018% +$8.87M ﹤0.01% 2636
2024
Q4
$756K Sell
44,365
-119,253
-73% -$2.06M ﹤0.01% 4809
2024
Q3
$2.4M Buy
163,618
+120,005
+275% +$1.5M ﹤0.01% 3859
2024
Q2
$495K Buy
43,613
+22,330
+105% +$244K ﹤0.01% 4693
2024
Q1
$231K Buy
+21,283
New +$213K ﹤0.01% 5271

Other funds holding BTSG

JP Morgan Chase's BTSG Position: Q1 2026 in Review

JP Morgan Chase increased its BrightSpring Health Services (BTSG) stake by 14% in Q1 2026, buying an estimated $1.05M and bringing the position to 209,823 shares worth $8.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

JP Morgan Chase first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.98M in Q1 2025. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • JP Morgan Chase held 209,823 shares of BrightSpring Health Services worth $8.72M as of Q1 2026.
  • JP Morgan Chase bought 26,142 BrightSpring Health Services shares in Q1 2026, an estimated $1.05M.
  • BrightSpring Health Services made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2810 holding.
  • JP Morgan Chase first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • JP Morgan Chase's BrightSpring Health Services position peaked at $8.98M in Q1 2025.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.